On May 20, 2025, Cardlytics, Inc. announced that shareholders approved the 2025 Equity Incentive Plan, allowing for the issuance of up to 15,722,908 shares. The approval also included the election of directors and ratification of Deloitte & Touche LLP as the independent auditors for the fiscal year 2025.